<DOC>
	<DOCNO>NCT00557544</DOCNO>
	<brief_summary>This Randomized double blind trial aim estimate effectiveness 3 therapeutic regime per o migraine pain : - metoclopramide 0,15 mg/kg + placebo - metoclopramide 0,15 mg/Kg + ketoprofen 1 mg/kg - ketoprofen 1 mg/Kg + placebo Intensity pain measure linear 1-10 scale analogic McGrath type scale every 20 min . The main objective evaluation heal time pain 3 group</brief_summary>
	<brief_title>Trial Metoclopramide Ketoprofen Acute Migraine Childhood</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Children 617 year old migraine presenting emergency room Informed consensus obtain Occurring migraine still treat Hemiplegic migraine</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>migraine</keyword>
	<keyword>metoclopramide</keyword>
	<keyword>ketoprofen</keyword>
	<keyword>child</keyword>
</DOC>